Europe Custom Antibody Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis

The Europe custom antibody services market is projected to grow significantly, reaching approximately US$ 395.31 million by 2031, up from US$ 194.22 million in 2023, with a compound annual growth rate (CAGR) of 9.3% during the forecast period.

Executive Summary and Market Analysis

The custom antibody services market in Europe is on a steady upward trajectory, primarily driven by the rising demand for personalized medicine, advancements in oncology and neurology research, and the growth of the biotech and pharmaceutical industries. Key European nations, including Germany, the UK, and France, are at the forefront of this growth due to their robust research infrastructure and substantial funding support. The increasing emphasis on targeted therapies and the adoption of recombinant antibodies are also significant factors contributing to market expansion. Furthermore, collaborations between academic institutions and contract research organizations (CROs) are fostering innovation, while regulatory support and technological advancements bolster Europe’s competitive edge in the global custom antibody services market.

Market Segmentation Analysis

The Europe custom antibody services market can be segmented based on product type, service type, application, disease indication, source, and end user:

Product Type: The market is divided into monoclonal, polyclonal, hybridoma, recombinant antibodies, and others. In 2023, monoclonal antibodies held the largest market share.
Service Type: This segment includes antibody discovery and development, antibody production services, and others, with antibody discovery and development leading in market share in 2023.
Application: The applications include immunohistochemistry, western blotting & immunoprecipitation (IP), ELISA, fluorescence-activated cell sorting, mass spectrometry, and others. ELISA was the dominant application in 2023.
Disease Indication: The market is segmented into oncology, infectious diseases, immunology, cardiovascular diseases, and others, with oncology being the largest segment in 2023.
Source: This includes chicken, rabbits, rats, guinea pigs, mouse or humanized mice, and others. The mouse or humanized mice segment had the largest share in 2023, further divided into various antibody platforms.
End User: The end users comprise the life science industry, pharmaceutical and biotech companies, academic and research institutes, and contract research organizations, with the life science industry leading in market share in 2023.

Market Outlook

Emerging countries are increasingly launching research and development initiatives focused on genomics and proteomics, with Europe making notable progress in genomics research through various initiatives and funding programs. The 1+ Million Genomes (1+MG) initiative, initiated in 2018, aims to enhance access to genomic and health data across Europe, supported by a €20 million grant for the Genome of Europe project. The Horizon Europe program, along with its predecessor Horizon 2020, has funded numerous genomics projects, including QUANTOMICS, which focuses on livestock genomics. Additionally, the Marie Sklodowska-Curie Actions (MSCA) provides €6.6 billion in fellowships for interdisciplinary research, including genomics, while EU4Health, with a budget of €5.1 billion, supports healthcare initiatives related to genomics. The rise in government-backed research initiatives is expected to create lucrative opportunities for the custom antibody services market in the coming years.

Country Insights

The Europe custom antibody services market includes countries such as the UK, Germany, France, Italy, Spain, and others, with Germany holding the largest market share in 2023. The anticipated growth in Germany is attributed to the increasing prevalence of chronic diseases, particularly cancer, which is a leading cause of morbidity and mortality. According to the World Health Organization (WHO), Germany reported 628,519 new cancer cases and 252,065 deaths in 2020. The rising cancer incidence drives the demand for targeted therapies, where custom antibodies can play a crucial role in improving treatment efficacy and minimizing side effects.

For instance, in September 2023, AMSBIO provided a custom monoclonal antibody to researchers at the Technical University Dortmund to study the role of EDI3 in breast cancer development, demonstrating the practical applications of custom antibodies in research.

The presence of various market players in Germany, such as BioGenes GmbH, which offers a wide range of custom antibodies and services, further supports market growth. The company is involved in product innovation and development, providing antibodies targeting various proteins and small molecules.

Company Profiles

Key players in the custom antibody services market include Thermo Fisher Scientific Inc., Sino Biological Inc., GenScript Biotech Corporation, Biochain Incorporated, R&D Systems, Inc., and others. These companies are employing strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to their customers.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe custom antibody services market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe custom antibody services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the custom antibody services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution. Show more